Gut microbiota and obesity: New study shows promising results with probiotic and prebiotic intervention

FHS
May 16, 2024
11:51 am

The effect of a low-calorie, sufficient fiber regimen combined with probiotic supplements and physical activity on health, body composition, and physique.

Asceneuron secures $100m for neurodegenerative treatments

Asceneuron’s lead compound, ASN51, is intended for Alzheimer’s disease treatment. Credit: fizkes/Shutterstock. Clinical-stage biotech company Asceneuron has announced an oversubscribed Series C financing round, securing

July 16, 2024

With new trial data, a blockbuster therapy from Sanofi, Regeneron could find an even bigger market

LONDON — The inflammation-targeting therapy Dupixent succeeded in a Phase 3 trial in patients with the chronic lung disease COPD, its developers said Monday, results

November 27, 2023

Pfizer’s Hospira issues recall after glass particles found in injectables – Pharmaceutical Technology

Pfizer’s subsidiary Hospira has issued several voluntary recalls to the FDA over the past few years. Credit: bankrx via Getty Images Hospira, a Pfizer company,

October 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.